Leiden University Medical Center
Clinical trials sponsored by Leiden University Medical Center, explained in plain language.
-
Weekly pill could revolutionize birth control without hormones
Disease control OngoingThis study tests whether taking mifepristone 50 mg once a week can safely prevent pregnancy. 615 women aged 18-35 will use it as their only birth control for one year. The goal is to see if it works well with fewer side effects than daily hormone pills.
Phase: PHASE3 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a 'Hotspotter' approach cut ER visits and improve lives?
Disease control OngoingThis study tests a new way of caring for 'hotspotters'—people with multiple health and social problems who frequently use emergency services. The approach brings together a doctor, mental health nurse, social worker, and the patient to create a personalized care plan, with a coor…
Phase: NA • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can deep sleep or nerve stimulation flush toxic proteins from the brain?
Disease control ENROLLING_BY_INVITATIONThis Phase 2 trial tests whether a sleep-deepening drug (lower-sodium oxybate) or a nerve-stimulating device (non-invasive vagus nerve stimulation), or both, can help clear amyloid-beta protein from the brain in people with cerebral amyloid angiopathy (CAA). Sixty participants wi…
Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
One-Size-Fits-No-One: study tailors blood thinner length to prevent repeat clots
Disease control OngoingThis study tests whether using a person's individual risk of another blood clot or major bleeding can help doctors decide how long they should take blood thinners after a first clot. About 600 adults who had a first deep vein thrombosis or pulmonary embolism will fill out a quest…
Phase: NA • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo attack on eye cancer that spreads to the liver
Disease control OngoingThis study tests a combination of two immunotherapy drugs (ipilimumab and nivolumab) plus a chemotherapy drug (melphalan) given directly to the liver through a special procedure. It includes 83 adults with advanced uveal melanoma that has spread mainly to the liver. The goal is t…
Phase: PHASE1, PHASE2 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jun 26, 2026 15:09 UTC
-
500 eye melanoma patients share their quality of life journey
Knowledge-focused OngoingThis study follows 500 people diagnosed with uveal melanoma (a rare eye cancer) for five years after treatment. Participants fill out questionnaires about their physical and mental well-being, treatment side effects, and decision-making. The goal is to learn how different treatme…
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Your gut bugs may hold the key to lung cancer therapy
Knowledge-focused OngoingThis study looks at whether bacteria in the gut and throat can predict how well stage III lung cancer patients respond to the immunotherapy drug durvalumab after chemoradiation. Researchers will collect stool, throat swabs, and breath samples from 126 participants to see if these…
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Brain scans reveal hidden vascular clues in early Alzheimer's
Knowledge-focused OngoingThis study uses MRI scans to track how blood vessels in the brain change over time in people with early Alzheimer's disease and healthy volunteers. Researchers aim to understand if reduced blood vessel reactivity is an early sign of dementia. The study involves 120 participants a…
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:27 UTC
-
New study probes brain inflammation to unlock dementia mysteries
Knowledge-focused OngoingThis observational study looks at how brain inflammation contributes to frontotemporal lobar degeneration (FTLD), a group of disorders that cause dementia. Researchers will use advanced brain scans, blood tests, and spinal fluid analysis in 110 participants to find biomarkers tha…
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:38 UTC
-
New risk tool aims to take the guesswork out of sarcoma treatment choices
Knowledge-focused OngoingThis study tests a tool called PERSARC that gives soft-tissue sarcoma patients personalized information about the risks and benefits of different treatment options. 120 adults with high-grade sarcoma in their arms or legs will either get standard care or care using PERSARC. The g…
Phase: NA • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:17 UTC